Synthesis Capital’s Investment in Arkeon Biotechnologies

Wolf Theiss advised Synthesis Capital on the deal.Synthesis Capital executed an investment in Arkeon Biotechnologies, a startup which uses an ancient microbe to turn CO2 into…

This content is for Standard 1 Year members only.
Login Join Now
Maha Kanaan

Author: Maha Kanaan

This content is for Standard 1 Year members only.
Login Join Now